CVTX: $10.60; +$0.48; +4.74%; Ranexa (goes by another name in Europe)approved in EU (about 30 countries.). Increases the chances the FDA will approve for one or more indications submitted (3 different ones). Getting to break even! Long haul because of Cramer!